Moderna Inc.

Latest Stories

FILE - A sign marks an entrance to a Moderna building in Cambridge, Mass., on May 18, 2020. (AP Photo/Bill Sikes, File)

Moderna lays out plan to slice research and development spending

Associated Press

A sign marks an entrance to a Moderna building in Cambridge, Mass., on Monday, May 18, 2020. Moderna shares slipped Tuesday, April 11, 2023, after the COVID-19 vaccine developer said its potential flu vaccine needs more study in a late-stage clinical trial. (AP Photo/Bill Sikes) **FILE**

Moderna says potential flu vaccine needs more study

Associated Press

World Health Organization Tedros Adhanom Ghebreyesus speaks during a media conference at an EU Africa summit in Brussels, Friday, Feb. 18, 2022. European Union leaders on Thursday lauded the bloc's vaccine cooperation with Africa in the fight against the coronavirus, but there was no sign they would move toward a temporary lifting of intellectual property rights protection for COVID-19 shots. (Johanna Geron, Pool Photo via AP)

WHO works to spread COVID vaccine technology to more nations

Associated Press

People wearing protective masks to help curb the spread of the coronavirus walk Wednesday, April 21, 2021, in Tokyo. The Japanese capital confirmed more than 840 new coronavirus cases on Wednesday. (AP Photo/Eugene Hoshiko)

Japan prepares for 3rd virus emergency in Tokyo, Osaka areas

By MARI YAMAGUCHI - Associated Press

A man wearing a face mask walks on a street during lunchtime in Tokyo on Thursday, March 4, 2021. (AP Photo/Hiro Komae)

Japan extends virus emergency for 2 weeks for Tokyo area

By MARI YAMAGUCHI - Associated Press

Travelers are screened before entering the Wuchang train station at the start of the annual Lunar New Year travel in Wuhan in central China's Hubei province on Thursday, Jan. 28, 2021. Efforts to dissuade Chinese from traveling for Lunar New Year appeared to be working as Beijing’s main train station was largely quiet and estimates of passenger totals were smaller than in past years. (AP Photo/Ng Han Guan)

Asia Today: China’s big holiday travel season light so far

Associated Press

Japanese Prime Minister Yoshihide Suga speaks during a meeting of the coronavirus infection control headquarters at his office in Tokyo Friday, Jan. 22, 2021. Suga, in a speech earlier, said the vaccine is “the clincher” in the fight against the pandemic and vowed to start vaccinations as soon as late February, when a health ministry approval of the Pfizer vaccine, the first applicant, is expected. (Kazuhiro Nogi/Pool Photo via AP)

Japan vaccination uncertainty casts doubts over Olympics

By MARI YAMAGUCHI - Associated Press

European Union medicines agency recommends approval of Moderna Inc.’s COVID-19 vaccine for use in th

Associated Press

FILE- In this Monday Dec. 1, 2020, file photo the exterior of the European Medicines Agency is seen in Amsterdam, Netherlands. The European Commission defended its coronavirus vaccination strategy Monday amid growing criticism in member states about the slow rollout of COVID-19 shots across the region with 450 million inhabitants. (AP Photo/Peter Dejong, File)

EU commission greenlights Moderna’s COVID-19 vaccine

By ALEKSANDAR FURTULA and MIKE CORDER - Associated Press

Boxes containing the Moderna COVID-19 vaccine are moved to the loading dock for shipping at the McKesson distribution center in Olive Branch, Miss., Sunday, Dec. 20, 2020. (AP Photo/Paul Sancya, Pool)

Panel: People over 75, essential workers next for vaccines

By JOHN HANNA and MIKE STOBBE - Associated Press

More than 4,000 Arkansas health workers get virus vaccine

Associated Press

FILE - In this July 27, 2020, file photo, a nurse prepares a shot as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. The U.S. is poised to give the green light as early as Friday, Dec. 18, to a second COVID-19 vaccine, a critical new weapon against the surging coronavirus. Doses of the vaccine developed by Moderna Inc. and the National Institutes of Health will give a much-needed boost to supplies as the biggest vaccination effort in the nation’s history continues. (AP Photo/Hans Pennink, File)

US clears Moderna vaccine for COVID-19, 2nd shot in arsenal

By LAURAN NEERGAARD and MATTHEW PERRONE - Associated Press

FILE - In this July 9, 2020, file photo, people hold up a banner while listening to a news conference outside San Quentin State Prison in San Quentin, Calif. One in five state and federal prisoners in the United States has tested positive for the coronavirus, a rate more than four times higher than the general population. In some states, more than half of prisoners have been infected, according to data collected by The Associated Press and The Marshall Project. (AP Photo/Eric Risberg, File)

VIRUS TODAY: 2nd vaccine approved; Pence receives shot on TV

By The Associated Press - Associated Press

Maryland U.S. Attorney’s Office seizes two fake domain names

Associated Press

FILE - In this June 30, 2020, file photo, people are dwarfed against the financial skyline as they take photos of the Merlion statue along the Marina Bay area in Singapore. Singapore has approved the use of Pfizer’s coronavirus vaccine and the first shipment will arrive by end of this month, Prime Minister Lee Hsien Loong said Monday, Dec. 14, 2020. (AP Photo/Yong Teck Lim, File)

Singapore approves use of Pfizer’s COVID-19 vaccine

Associated Press

In this July 27, 2020, file photo, nurse Kathe Olmstead prepares a shot that is part of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., in Binghamton, N.Y. Moderna Inc. says it will ask U.S. and European regulators to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection. (AP Photo/Hans Pennink, File)

Moderna asking US, European regulators to OK its virus shots

By Lauran Neergaard - Associated Press

FILE - In this Monday, March 16, 2020 file photo, Neal Browning receives a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus at the Kaiser Permanente Washington Health Research Institute in Seattle. A panel of U.S. advisers will meet this week to recommend who should be first in line for a COVID-19 vaccine. Experts have proposed giving the vaccine to health workers first. High priority also may be given to workers in essential industries, people with certain medical conditions and people age 65 and older. (AP Photo/Ted S. Warren, File)

CDC panel meets Tuesday to vote on COVID-19 vaccine priority

Associated Press

This May 4, 2020, file photo provided by the University of Maryland School of Medicine, shows the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore. Pfizer announced Wednesday, Nov. 18, 2020, more results in its ongoing coronavirus vaccine study that suggest the shots are 95% effective a month after the first dose. (Courtesy of University of Maryland School of Medicine via AP, File)

Coronavirus vaccine priority: CDC panel to vote Tuesday

Associated Press

FILE - In this March 16, 2020, file photo, Neal Browning receives a shot in the first-stage safety study of a potential vaccine for COVID-19 at the Kaiser Permanente Washington Health Research Institute in Seattle. Moderna Inc., said Monday, Nov. 16, its COVID-19 vaccine is proving to be highly effective in a major trial. (AP Photo/Ted S. Warren, File)

Volunteers still needed to test variety of COVID-19 vaccines

By LAURAN NEERGAARD - Associated Press

Pedestrians walk past Pfizer world headquarters in New York on Monday Nov. 9, 2020. Pfizer says an early peek at its vaccine data suggests the shots may be 90% effective at preventing COVID-19, but it doesn't mean a vaccine is imminent. (AP Photo/Bebeto Matthews)

Testing timeline: What’s ahead for COVID-19 vaccines

By LAURAN NEERGAARD - Associated Press